Page last updated: 2024-10-27

flumazenil and Tay-Sachs Disease

flumazenil has been researched along with Tay-Sachs Disease in 1 studies

Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.

Tay-Sachs Disease: An autosomal recessive neurodegenerative disorder characterized by the onset in infancy of an exaggerated startle response, followed by paralysis, dementia, and blindness. It is caused by mutation in the alpha subunit of the HEXOSAMINIDASE A resulting in lipid-laden ganglion cells. It is also known as the B variant (with increased HEXOSAMINIDASE B but absence of hexosaminidase A) and is strongly associated with Ashkenazic Jewish ancestry.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
AVCIN, M1
JERAS, J1
SILC, M1

Other Studies

1 other study available for flumazenil and Tay-Sachs Disease

ArticleYear
[Two cases of amaurotic idiocy in a gypsy family].
    Zdravstveni vestnik, 1953, Volume: 22, Issue:5

    Topics: Humans; Intellectual Disability; Neuronal Ceroid-Lipofuscinoses; Roma; Tay-Sachs Disease

1953